Haemonetics Corporation
HAE
$57.00
-$0.17-0.30%
NYSE
| 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 20.02% | 35.82% | -6.50% | -30.68% | -5.17% |
| Total Depreciation and Amortization | 23.35% | 26.19% | 27.28% | 24.00% | -0.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.11% | -- |
| Total Other Non-Cash Items | -33.76% | -20.31% | -280.09% | -84.68% | 0.14% |
| Change in Net Operating Assets | 54.47% | -194.80% | -59.72% | 59.68% | -1,351.89% |
| Cash from Operations | 8,204.81% | -50.75% | -243.67% | -19.51% | -100.84% |
| Capital Expenditure | 35.22% | 51.42% | -2.11% | 18.74% | -32.32% |
| Sale of Property, Plant, and Equipment | -25.74% | -63.58% | 4,965.17% | 109.05% | 113.92% |
| Cash Acquisitions | 100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.66% | -882.50% | 90.98% | -- | 84.20% |
| Cash from Investing | 93.54% | 7.03% | -812.11% | 27.49% | -636.81% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 55.37% | 100.00% | -33,486.46% | -3,528.57% | 93.24% |
| Issuance of Common Stock | 21.32% | -63.73% | 25.84% | -33.33% | 40.36% |
| Repurchase of Common Stock | -944.19% | -1,621.59% | -557.45% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -375.93% | -120.00% | -2,587.95% | -800.00% | 700.00% |
| Cash from Financing | -98.74% | -943.00% | 55,901.34% | -3,861.45% | 320.27% |
| Foreign Exchange rate Adjustments | -305.63% | 374.46% | 26.80% | -684.63% | -33.85% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 113.73% | -169.15% | 13,118.60% | -125.10% | -813.05% |